← Leaderboards
Rosemary D Leake
La Biomed Res Inst/ Harbor Ucla Med Ctr
$477,920
Attributed
$477,920
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$477,920 · 2
By mechanism
M01$477,920 · 2
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Michael Glenn Ross$10,022,584
- Frans Walther$477,920
- John Steven Torday$3,425,151
- Frans J. Walther$4,304,095
- Alan H Jobe$12,083,009
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionHuman SubjectHuman Therapy EvaluationClinical ResearchHormone TherapyClinical TrialsLow Birth Weight Infant HumanLung DisorderNewborn Human (0-6 Weeks)Outcomes ResearchPituitary Thyroid AxisPremature LaborRespiratory Distress Syndrome Of NewbornThyrotropin Releasing HormoneBronchopulmonary DysplasiaThyroxineChronic Obstructive Pulmonary DiseaseDrug Screening /EvaluationFemaleHuman MorbidityHuman Pregnant Subject
Grant awards (4)
TRH AND PREVENTION OF BRONCHOPULMONARY DYSPLASIA$237,978
M01 · FY2001 · RR
RANDOMIZED STUDY OF THYROXINE TREATMENT OF VERY LOW BIRTH WEIGHT INFANTS$237,978
M01 · FY2001 · RR
TRH AND PREVENTION OF BRONCHOPULMONARY DYSPLASIA$982
M01 · FY2000 · RR
RANDOMIZED STUDY OF THYROXINE TREATMENT OF VERY LOW BIRTH WEIGHT INFANTS$982
M01 · FY2000 · RR